dromlakhani/md2skill/ata-prolactinoma-axis-reassess

Claude Code and agent skill by dromlakhani/md2skill

Trust tier 3
  • community
Source check pending

Checking that the SKILL.md file is still in the repository.

Recommends reassessing all pituitary axes in patients with macroprolactinoma and central hypogonadism who have had successful dopamine agonist treatment. Use when managing a macroprolactinoma patient after dopamine agonist treatment with normalized prolactin and tumor shrinkage.

Install

npx vskill@latest install dromlakhani/md2skill/ata-prolactinoma-axis-reassess

SKILL.md

The same SKILL.md was published earlier as dromlakhani/md2skill/ata-prolactinoma-axis-reassess.

Reassess pituitary axes after dopamine agonist treatment in macroprolactinoma

STEP 1 — Gather Information

Confirm macroprolactinoma diagnosis (MRI >10mm), central hypogonadism (low testosterone/E2 with inappropriately low LH/FSH), and successful dopamine agonist treatment (normoprolactinemia, tumor shrinkage ≥30%, symptom improvement). Collect baseline pituitary hormones (cortisol, fT4, TSH, IGF-1, gonadotropins, sex steroids) and current symptoms.

STEP 2 — Rule In / Rule Out

Is there evidence of successful dopamine agonist treatment? If yes, proceed to axis reassessment; if no, optimize dopamine agonist dose or consider surgery/radiation before reassessment.

STEP 3 — Classify or Stratify

Assess each pituitary axis: adrenal (AM cortisol or ACTH stim), thyroid (fT4/TSH), gonadal (testosterone/E2, LH/FSH), GH (IGF-1), and DI (serum/urine osmolarity if polyuria). Classify each as sufficient, borderline, or deficient based on age-adjusted reference ranges.

STEP 4 — Decide

For any deficient axis, initiate appropriate hormone replacement per endocrine guidelines; for borderline, repeat testing in 3-6 months; for sufficient, continue surveillance with annual clinical review and pituitary MRI.

Clinical Guardrails / Mimics / Pitfalls

Do not assume normalization of prolactin implies recovery of other axes; do not discontinue dopamine agonist without confirming tumor stability; avoid empiric hormone replacement without biochemical confirmation; consider macroprolactinoma regrowth if symptoms worsen despite biochemical control.

Concrete Clinical Example

A 42-year-old man with macroprolactinoma (12mm) and central hypogonadism (testosterone 150 ng/dL, LH 1.2 IU/L) achieved normoprolactinemia (<20 ng/mL) and 50% tumor shrinkage after 6 months of cabergoline. Reassessment revealed low IGF-1 (80 ng/mL) and low testosterone (120 ng/dL); he started testosterone gel and GH replacement.

Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118

Security

  • Security scanPassed, 100 of 100Pattern checks on the skill's files.
  • Model reviewPassed

Quality evaluation

  • Task evaluationNot runNo evaluation yet. Run one in Skill Studio.

Source

Popularity

Repository stars
12
Repository forks
1
7-day trend score
18

Stars and forks are for the whole GitHub repository, not this skill alone. Not refreshed yet.

Works with

Any agent vskill installs to: 56 targets in all. These 39 have a page on this site.

  • Claude Code
  • Cursor
  • GitHub Copilot
  • Windsurf
  • Codex
  • Gemini CLI
  • Cline
  • Amp
  • Roo Code
  • Goose
  • Continue
  • Kilo Code
  • Junie
  • Trae
  • OpenHands
  • Qwen Code
  • AI Agent
  • Tabnine Chat
  • Sourcegraph Cody
  • Amazon Q
  • Firebase Genkit
  • Sweep
  • Devin
  • Phind
  • Mentat
  • Claude Desktop
  • Aider
  • GPT Pilot
  • Plandex
  • bolt.new
  • v0
  • Replit Agent
  • Anse
  • TypingMind
  • BetterChatGPT
  • LibreChat
  • Warp AI
  • Pieces
  • Fig AI
Embed badge
vskill VERIFIED badge
[![vskill VERIFIED](https://verified-skill.com/api/v1/skills/dromlakhani/md2skill/ata-prolactinoma-axis-reassess/badge)](https://verified-skill.com/skills/dromlakhani/md2skill/ata-prolactinoma-axis-reassess)

Something wrong with this skill or its page? Tell us.